Regulation of transcriptional activity during the first and second cell cycles in the preimplantation mouse embryo.
Transcription of endogenous genes in preimplantation 1- and 2-cell mouse embryos was determined by monitoring the incorporation of BrUTP by plasma membrane-permeabilized embryos. Incorporation is observed starting by mid-S phase in the 1-cell embryo and increases progressively; the amount of incorporation by the 1-cell embryo in G2 is about 20% that of the 2-cell embryo in G2. Incorporation by the male pronucleus is always about four to five times greater than that of the female pronucleus. Nevertheless, the amount of incorporation by the female pronucleus present in parthogenetically activated eggs is similar to the total amount of incorporation in inseminated eggs, i.e., the transcriptional capacity of the female pronucleus is not inherently less than that of the male pronucleus. Inhibiting the first round of DNA replication does not prevent the initiation of transcription in the 1-cell embryo, but does inhibit the extent of BrUTP incorporation by 35%. The transcriptional machinery of the 1-cell embryo appears to be rate-limiting, since the total amount of BrUTP incorporation by parthenogenetically activated and dispermic eggs is similar to that in monospermic eggs; trispermic eggs incorporate BrUTP to only about 60% the level of monospermic eggs. A transcriptionally repressive state may start to develop in the 2-cell embryo, since inhibiting the second round of DNA replication results in an 50% increase in BrUTP incorporation. Trapoxin treatment, which induces histone hyperacetylation, enhances incorporation by 2-cell embryos 1.8-fold and suggests that histone hyperacetylation can relieve this repression.
Aoki
F
F
Department of Biology, University of Pennsylvania, Philadelphia 19104-6018, USA.
Worrad
D M
DM
Schultz
R M
RM
D000107:Acetylation / Q000187:drug effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016590:Aphidicolin / Q000494:pharmacology; D001755:Blastocyst / Q000166:cytology*; D002453:Cell Cycle / Q000235:genetics*; D002463:Cell Membrane Permeability; D004261:DNA Replication / Q000187:drug effects; D005260:Female; D016195:G2 Phase; D018507:Gene Expression Regulation, Developmental; D017930:Genes, Reporter; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000502:physiology; D006657:Histones / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018613:Microscopy, Confocal; D010312:Parthenogenesis; D010455:Peptides; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D016196:S Phase; D013084:Sperm-Ovum Interactions; D014158:Transcription, Genetic
D000900:Anti-Bacterial Agents; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D010455:Peptides; C067070:trapoxin A; D016590:Aphidicolin; D006655:Histone Deacetylases